| __timestamp | CRISPR Therapeutics AG | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 5114000 | 24518692 |
| Thursday, January 1, 2015 | 13403000 | 19886580 |
| Friday, January 1, 2016 | 31056000 | 12631689 |
| Sunday, January 1, 2017 | 35845000 | 21977998 |
| Monday, January 1, 2018 | 48294000 | 20759000 |
| Tuesday, January 1, 2019 | 63488000 | 20838000 |
| Wednesday, January 1, 2020 | 88208000 | 121812000 |
| Friday, January 1, 2021 | 102802000 | 152137000 |
| Saturday, January 1, 2022 | 102464000 | 83231000 |
| Sunday, January 1, 2023 | 76162000 | 122706000 |
Unlocking the unknown
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. Over the past decade, TG Therapeutics, Inc. and CRISPR Therapeutics AG have shown contrasting strategies in optimizing these costs. From 2014 to 2023, TG Therapeutics, Inc. saw a staggering 400% increase in SG&A expenses, peaking in 2021. In contrast, CRISPR Therapeutics AG maintained a more consistent growth, with a 1,400% rise over the same period, reaching its highest in 2021. Interestingly, 2023 marked a shift, with CRISPR reducing its expenses by 26% from the previous year, while TG Therapeutics increased by 47%. This data highlights the dynamic nature of cost management in biotech, where strategic financial planning can significantly impact a company's competitive edge.
Comparing SG&A Expenses: Eli Lilly and Company vs CRISPR Therapeutics AG Trends and Insights
Breaking Down SG&A Expenses: Johnson & Johnson vs TG Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Teva Pharmaceutical Industries Limited and CRISPR Therapeutics AG
Who Optimizes SG&A Costs Better? Viatris Inc. or CRISPR Therapeutics AG
Operational Costs Compared: SG&A Analysis of Opthea Limited and CRISPR Therapeutics AG
Operational Costs Compared: SG&A Analysis of TG Therapeutics, Inc. and MorphoSys AG
Who Optimizes SG&A Costs Better? TG Therapeutics, Inc. or Agios Pharmaceuticals, Inc.
Comparing SG&A Expenses: TG Therapeutics, Inc. vs Celldex Therapeutics, Inc. Trends and Insights
CRISPR Therapeutics AG and Bausch Health Companies Inc.: SG&A Spending Patterns Compared
CRISPR Therapeutics AG or HUTCHMED (China) Limited: Who Manages SG&A Costs Better?
CRISPR Therapeutics AG or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of CRISPR Therapeutics AG and Viridian Therapeutics, Inc.